IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 59 filers reported holding IMMUNOCORE HLDGS PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,296,542 | -13.4% | 82,785 | 0.0% | 0.01% | -14.3% |
| Q2 2023 | $4,963,789 | -39.4% | 82,785 | -50.0% | 0.01% | -41.7% |
| Q1 2023 | $8,185,830 | -13.4% | 165,571 | 0.0% | 0.01% | -20.0% |
| Q4 2022 | $9,449,137 | -28.2% | 165,571 | -40.9% | 0.02% | -31.8% |
| Q3 2022 | $13,160,000 | +30.8% | 280,361 | 0.0% | 0.02% | +46.7% |
| Q2 2022 | $10,065,000 | +20.9% | 280,361 | 0.0% | 0.02% | +36.4% |
| Q1 2022 | $8,327,000 | – | 280,361 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $28,523,073 | 25.19% |
| Velan Capital Investment Management LP | 200,000 | $9,888,000 | 8.43% |
| RTW INVESTMENTS, LP | 5,649,943 | $279,333,182 | 5.82% |
| Paradigm Biocapital Advisors LP | 1,126,256 | $55,682,097 | 5.28% |
| Rock Springs Capital Management LP | 3,001,662 | $148,402,169 | 3.54% |
| Logos Global Management LP | 500,000 | $24,720,000 | 3.54% |
| TANG CAPITAL MANAGEMENT LLC | 405,600 | $20,052,864 | 2.99% |
| GREAT POINT PARTNERS LLC | 255,367 | $12,625,344 | 2.48% |
| COWEN AND COMPANY, LLC | 405,174 | $20,031,802 | 2.35% |
| Eschler Asset Management LLP | 60,000 | $2,966,400 | 2.34% |